Literature DB >> 18160141

Controlled inactivation of recombinant viruses with vitamin B2.

Shellie M Callahan1, Piyanuch Wonganan, Linda J Obenauer-Kutner, Suganto Sutjipto, Joseph D Dekker, Maria A Croyle.   

Abstract

Inactivated viruses are important tools for vaccine development and gene transfer. 8-Methoxypsoralen (8-MOP) and long-wavelength ultraviolet irradiation (LWUVI) inactivates many viruses. Toxicity limits its use in animals and humans. Toxicological and photosensitizing properties of riboflavin make it suitable for virus inactivation in preparations for biological use. Viruses expressing beta-galactosidase were mixed with either 8-MOP (1.5mM) or riboflavin (50 microM) and exposed to LWUVI (365 nm) for 2 h. Virus activity was determined by limiting dilution. The half-life of the adenovirus preparation treated with 8-MOP was 8.28 ns(-1) and 36.5 ns(-1) after treatment with riboflavin. Despite the difference in half-life, both preparations were completely inactivated within 45 min. In contrast, the half-lives for adeno-associated virus (AAV) preparations were similar (63 ns(-1) 8-MOP vs. 67 ns(-1) riboflavin). Each AAV preparation was fully inactivated within 90 min. The half-life of lentivirus was 193.4 ns(-1) after treatment with 8-MOP and 208 ns(-1) after exposure to riboflavin. Virus treated with riboflavin was inactivated within 20 min. Virus exposed to 8-MOP was inactivated in 90 min. DNA and RNA viruses can be inactivated by riboflavin and LWUVI and used in physiological systems sensitive to other photochemicals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160141      PMCID: PMC2346443          DOI: 10.1016/j.jviromet.2007.10.027

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  52 in total

1.  Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

Authors:  M A Schnell; Y Zhang; J Tazelaar; G P Gao; Q C Yu; R Qian; S J Chen; A N Varnavski; C LeClair; S E Raper; J M Wilson
Journal:  Mol Ther       Date:  2001-05       Impact factor: 11.454

2.  The use of field emission scanning electron microscopy to assess recombinant adenovirus stability.

Authors:  Linda J Obenauer-Kutner; Peter M Ihnat; Tong-Yuan Yang; Barbara J Dovey-Hartman; Arthi Balu; Constance Cullen; Ronald W Bordens; Michael J Grace
Journal:  Hum Gene Ther       Date:  2002-09-20       Impact factor: 5.695

Review 3.  Innate immune response induced by gene delivery vectors.

Authors:  Haruna Sakurai; Kenji Kawabata; Fuminori Sakurai; Shinsaku Nakagawa; Hiroyuki Mizuguchi
Journal:  Int J Pharm       Date:  2007-06-16       Impact factor: 5.875

4.  Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.

Authors:  P C Ho; D J Saville; S Wanwimolruk
Journal:  J Pharm Pharm Sci       Date:  2001 Sep-Dec       Impact factor: 2.327

Review 5.  Pathogen inactivation of blood components: current status and introduction of an approach using riboflavin as a photosensitizer.

Authors:  Frank Corbin
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  Adenovirus vector-induced expression of the C-X-C chemokine IP-10 is mediated through capsid-dependent activation of NF-kappaB.

Authors:  S L Borgland; G P Bowen; N C Wong; T A Libermann; D A Muruve
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Significance of the type and the size of biomaterial particles on phagocytosis and tissue distribution.

Authors:  V J Tomazic-Jezic; K Merritt; T H Umbreit
Journal:  J Biomed Mater Res       Date:  2001-06-15

8.  Comparative inactivation of enteroviruses and adenovirus 2 by UV light.

Authors:  Charles P Gerba; Dawn M Gramos; Nena Nwachuku
Journal:  Appl Environ Microbiol       Date:  2002-10       Impact factor: 4.792

9.  Binding affinities of commonly employed sensitizers of viral inactivation.

Authors:  Nathalie Dardare; Matthew S Platz
Journal:  Photochem Photobiol       Date:  2002-06       Impact factor: 3.421

10.  Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column.

Authors:  A Auricchio; M Hildinger; E O'Connor; G P Gao; J M Wilson
Journal:  Hum Gene Ther       Date:  2001-01-01       Impact factor: 5.695

View more
  8 in total

1.  Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity.

Authors:  Jin Huk Choi; Joe Dekker; Stephen C Schafer; Jobby John; Craig E Whitfill; Christopher S Petty; Eid E Haddad; Maria A Croyle
Journal:  Clin Vaccine Immunol       Date:  2011-11-16

2.  Evaluation of the HC-04 cell line as an in vitro model for mechanistic assessment of changes in hepatic cytochrome P450 3A during adenovirus infection.

Authors:  Piyanuch Wonganan; Kristina Jonsson-Schmunk; Shellie M Callahan; Jin Huk Choi; Maria A Croyle
Journal:  Drug Metab Dispos       Date:  2014-04-24       Impact factor: 3.922

Review 3.  Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers.

Authors:  Charles A Abbas; Andriy A Sibirny
Journal:  Microbiol Mol Biol Rev       Date:  2011-06       Impact factor: 11.056

4.  Integrin Receptors Play a Key Role in the Regulation of Hepatic CYP3A.

Authors:  Kristina Jonsson-Schmunk; Piynauch Wonganan; Jin Huk Choi; Shellie M Callahan; Maria A Croyle
Journal:  Drug Metab Dispos       Date:  2016-02-11       Impact factor: 3.922

5.  Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus.

Authors:  Piyanuch Wonganan; Courtney C Clemens; Kathy Brasky; Lucio Pastore; Maria A Croyle
Journal:  Mol Pharm       Date:  2010-09-23       Impact factor: 4.939

6.  Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola Vaccine.

Authors:  Jin Huk Choi; Stephen C Schafer; Alexander N Freiberg; Maria A Croyle
Journal:  Mol Pharm       Date:  2015-01-20       Impact factor: 4.939

Review 7.  Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes.

Authors:  Simon Elveborg; Vanessa M Monteil; Ali Mirazimi
Journal:  Pathogens       Date:  2022-02-19

8.  Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection.

Authors:  Shellie M Callahan; Piyanuch Wonganan; Maria A Croyle
Journal:  Virol J       Date:  2008-09-30       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.